JPWO2022014680A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022014680A5
JPWO2022014680A5 JP2022536446A JP2022536446A JPWO2022014680A5 JP WO2022014680 A5 JPWO2022014680 A5 JP WO2022014680A5 JP 2022536446 A JP2022536446 A JP 2022536446A JP 2022536446 A JP2022536446 A JP 2022536446A JP WO2022014680 A5 JPWO2022014680 A5 JP WO2022014680A5
Authority
JP
Japan
Prior art keywords
octan
azabicyclo
represented
formula
fluoropyrimidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022536446A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022014680A1 (https=
JP7190612B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/026649 external-priority patent/WO2022014680A1/ja
Publication of JPWO2022014680A1 publication Critical patent/JPWO2022014680A1/ja
Application granted granted Critical
Publication of JP7190612B2 publication Critical patent/JP7190612B2/ja
Publication of JPWO2022014680A5 publication Critical patent/JPWO2022014680A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022536446A 2020-07-17 2021-07-15 置換ピペリジン化合物及びその用途 Active JP7190612B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020122864 2020-07-17
JP2020122864 2020-07-17
PCT/JP2021/026649 WO2022014680A1 (ja) 2020-07-17 2021-07-15 置換ピペリジン化合物及びその用途

Publications (3)

Publication Number Publication Date
JPWO2022014680A1 JPWO2022014680A1 (https=) 2022-01-20
JP7190612B2 JP7190612B2 (ja) 2022-12-15
JPWO2022014680A5 true JPWO2022014680A5 (https=) 2022-12-16

Family

ID=79291962

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022536446A Active JP7190612B2 (ja) 2020-07-17 2021-07-15 置換ピペリジン化合物及びその用途

Country Status (23)

Country Link
US (1) US11479552B2 (https=)
EP (1) EP4151277B1 (https=)
JP (1) JP7190612B2 (https=)
KR (1) KR20230040953A (https=)
CN (3) CN119235864A (https=)
AR (1) AR122973A1 (https=)
AU (1) AU2021308053A1 (https=)
BR (1) BR112022026161A2 (https=)
CA (1) CA3187835A1 (https=)
CL (1) CL2022003666A1 (https=)
CO (1) CO2022018446A2 (https=)
DK (1) DK4151277T3 (https=)
FI (1) FI4151277T3 (https=)
IL (1) IL299125B2 (https=)
JO (1) JOP20220345A1 (https=)
LT (1) LT4151277T (https=)
MX (1) MX2022016388A (https=)
PE (1) PE20231103A1 (https=)
PH (1) PH12022553488A1 (https=)
TW (1) TWI888599B (https=)
UA (1) UA129636C2 (https=)
WO (1) WO2022014680A1 (https=)
ZA (1) ZA202213562B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4065585B1 (en) 2019-11-25 2025-08-20 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment
US11760747B2 (en) 2020-12-21 2023-09-19 Alkermes, Inc. Substituted piperidino compounds and related methods of treatment
US12006330B2 (en) 2020-12-21 2024-06-11 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment
JP7591592B2 (ja) * 2022-01-14 2024-11-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 置換ピペリジン化合物を含有する医薬
JPWO2023136279A1 (https=) * 2022-01-14 2023-07-20
WO2024075825A1 (ja) * 2022-10-07 2024-04-11 キッセイ薬品工業株式会社 シクロペンタン化合物
EP4611745A1 (en) * 2022-10-31 2025-09-10 Takeda Pharmaceutical Company Limited Dosing of orexin type 2 receptor agonists
WO2024128305A1 (ja) 2022-12-16 2024-06-20 第一三共株式会社 2-アザビシクロ[3.1.1]ヘプタン化合物
EP4719397A1 (en) 2023-06-02 2026-04-08 Takeda Pharmaceutical Company Limited Use of an orexin 2 receptor agonist for improving respiratory function during sleep
WO2025124698A1 (en) 2023-12-12 2025-06-19 Idorsia Pharmaceuticals Ltd Aryl sulfone and sulfanone derivatives as orexin receptor modulators
TW202542165A (zh) 2023-12-19 2025-11-01 瑞士商愛杜西亞製藥有限公司 大環食慾素激動劑
WO2025137359A1 (en) 2023-12-20 2025-06-26 Eisai R&D Management Co., Ltd. Assay methods to identify a disease
WO2025229493A1 (en) 2024-04-29 2025-11-06 Takeda Pharmaceutical Company Limited Dosing of orexin type 2 receptor agonists

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG34208A1 (en) 1995-03-01 1996-12-06 Guy Andrew Vaz Blast and fragment resistant polyurethane boot sole for safety footwear
EP0828751A4 (en) 1995-05-05 1999-01-20 Human Genome Sciences Inc HUMAN NEUROPEPTIDE RECEPTOR
US6309854B1 (en) 1996-12-17 2001-10-30 Smithkline Beecham Corporation Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
US6159605A (en) 1997-02-18 2000-12-12 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Ink-jet recording sheet
US5935814A (en) 1997-04-30 1999-08-10 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72Y receptor
US6020157A (en) 1997-04-30 2000-02-01 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72X receptor
US6166193A (en) 1997-07-25 2000-12-26 Board Of Regents, University Of Texas System Polynucleotides encoding MY1 receptor
KR100327888B1 (ko) 1999-07-14 2002-03-09 정숭렬 도로포장 파손촉진 시험장치의 무선제어 시스템
AU2004274309B2 (en) * 2003-09-22 2010-04-08 Msd K.K. Novel piperidine derivative
EP1805183B1 (en) 2004-10-20 2010-12-29 NeuroSearch A/S Novel diazabicyclic aryl derivatives and their medical use
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
TW201444849A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途

Similar Documents

Publication Publication Date Title
JPWO2022014680A5 (https=)
JP2025094100A5 (https=)
JP2023116721A5 (https=)
JP2021530451A5 (https=)
JP2009545527A5 (https=)
JP2021518134A5 (https=)
PE20231103A1 (es) Compuestos de piperidina sustituida y su uso
JP2010507641A5 (https=)
JP2009530282A5 (https=)
JP2018513215A5 (https=)
JP2009502743A5 (https=)
JP2022116141A5 (https=)
JP2007503202A5 (https=)
JP2008526830A5 (https=)
JP2007302683A5 (https=)
JP2005053931A5 (https=)
JP2017505777A5 (https=)
JP2017214410A5 (https=)
JP2012533601A5 (https=)
IL294247B1 (en) (2r,4r)-1-(3-chloro-2-fluorobenzyl)-4-((5-fluoro-4-methyl-6-((5-methyl-1h-pyrazol-3-yl)amino)pyridin-2-yl)methyl)-2-methylpiperidine-4-carboxylic acid and a pharmaceutical composition comprising the compound or pharmaceutically acceptable salt thereof
JP2007513875A5 (https=)
WO2021127097A3 (en) Organic-based nicotine gel compositions
JP2008513510A5 (https=)
JP2019151627A5 (https=)
RU2427573C2 (ru) Новые производные бензимидазола в качестве ингибиторов ваниллоидного рецептора 1 (vr1)